RAPP
Rapport Therapeutics, Inc.
Company overview
- Market capitalization
- $1.60B
- Employees
- 84
- Latest publication
- 2026-09-29
About Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company's lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. It also develops nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and migraine; and a9a10 nAChR for the treatment of hearing/vestibular disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 20,000,000USD | 0USD | 0USD | 0USD | 0USD | 720,000USD | 0USD |
| Research Development | 51,414,000USD | 32,716,000USD | 30,258,000USD | 22,279,000USD | 22,680,000USD | 19,572,000USD | 17,199,000USD | 15,543,000USD |
| Selling General Administrative | 9,392,000USD | 11,499,000USD | 8,251,000USD | 7,707,000USD | 6,816,000USD | 7,536,000USD | 6,322,000USD | 6,097,000USD |
| Total Operating Expenses | 60,806,000USD | 43,988,000USD | 38,244,000USD | 29,986,000USD | 29,496,000USD | 27,108,000USD | 23,521,000USD | 21,640,000USD |
| Operating Income | -60,806,000USD | -24,215,000USD | -38,509,000USD | -29,986,000USD | -29,496,000USD | -27,108,000USD | -23,521,000USD | -21,640,000USD |
| Total Other Income Expense Net | 4,191,000USD | 4,358,000USD | 4,746,000USD | 3,061,000USD | 2,764,000USD | 3,045,000USD | 3,541,000USD | 4,103,000USD |
| Interest Income | 4,191,000USD | 4,358,000USD | 4,746,000USD | 3,061,000USD | 2,764,000USD | 3,045,000USD | 3,541,000USD | 4,103,000USD |
| Net Income | -56,615,000USD | -19,857,000USD | -33,763,000USD | -26,925,000USD | -26,732,000USD | -24,063,000USD | -19,980,000USD | -17,537,000USD |
| Cost Of Revenue | — | 227,000USD | 265,000USD | 256,000USD | 252,000USD | 244,000USD | 260,000USD | 219,000USD |
| Gross Profit | — | 19,773,000USD | -265,000USD | -256,000USD | -252,000USD | -244,000USD | -260,000USD | -219,000USD |
| Net Interest Income | — | 4,358,000USD | 4,746,000USD | 3,061,000USD | 2,764,000USD | 3,045,000USD | 3,541,000USD | 4,103,000USD |
| Income Before Tax | — | -19,857,000USD | -33,763,000USD | -26,925,000USD | -26,732,000USD | -24,063,000USD | -19,980,000USD | -17,537,000USD |
| Net Income From Continuing Ops | — | -19,857,000USD | -33,763,000USD | -26,925,000USD | -26,732,000USD | -24,063,000USD | -19,980,000USD | -17,537,000USD |
| Ebit | — | -24,215,000USD | -38,508,999USD | -26,925,000USD | -29,496,000USD | -27,108,000USD | -23,521,000USD | -21,640,000USD |
| Ebitda | — | -23,988,000USD | -38,244,000USD | -26,669,000USD | -29,244,000USD | -26,864,000USD | -23,261,000USD | -21,421,000USD |
| Depreciation And Amortization | — | 227,000USD | 264,999USD | 256,000USD | 252,000USD | 244,000USD | 260,000USD | 219,000USD |
| Reconciled Depreciation | — | 227,000USD | 265,000USD | 256,000USD | 252,000USD | 244,000USD | 260,000USD | 219,000USD |
| Tax Provision | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 1,016,999USD | 839,000USD | 112,000USD | 15,000USD |
| Gross Profit | -1,016,999USD | -839,000USD | -112,000USD | -15,000USD |
| Research Development | 94,789,000USD | 60,935,000USD | 27,999,000USD | 9,115,000USD |
| Selling General Administrative | 30,310,000USD | 22,120,000USD | 8,180,000USD | 1,365,818USD |
| Total Operating Expenses | 125,099,000USD | 82,216,000USD | 36,067,000USD | 10,352,000USD |
| Operating Income | -125,099,000USD | -83,055,000USD | -36,179,000USD | -10,367,000USD |
| Interest Income | 13,616,000USD | 12,138,000USD | 2,527,000USD | — |
| Net Interest Income | 13,616,000USD | 12,138,000USD | 2,527,000USD | — |
| Income Before Tax | -111,483,000USD | -78,307,000USD | -34,776,000USD | -10,652,000USD |
| Net Income | -111,483,000USD | -78,307,000USD | -34,786,000USD | -10,652,000USD |
| Net Income From Continuing Ops | -111,483,000USD | -78,307,000USD | -34,786,000USD | — |
| Ebit | -125,099,000USD | -78,307,000USD | -34,776,000USD | -10,367,000USD |
| Ebitda | -124,082,000USD | -77,468,000USD | -34,664,000USD | -10,352,000USD |
| Depreciation And Amortization | 1,017,000USD | 839,000USD | 112,000USD | 15,000USD |
| Reconciled Depreciation | 1,017,000USD | 839,000USD | 112,000USD | — |
| Total Other Income Expense Net | 13,616,000USD | 4,748,000USD | 1,403,000USD | -285,000USD |
| Tax Provision | — | 0USD | 10,000USD | — |
| Selling And Marketing Expenses | — | — | 112,000USD | — |
| Interest Expense | — | — | 0USD | 285,000USD |
| Income Tax Expense | — | — | 10,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 458,982,000USD | 497,597,000USD | 512,431,000USD | 535,323,000USD | 285,495,000USD | 302,053,000USD | 314,933,000USD | 331,144,000USD |
| Cash And Equivalents | 63,612,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 436,077,000USD | 476,782,000USD | 490,539,000USD | 513,026,000USD | 260,447,000USD | 285,382,000USD | 305,280,000USD | 320,661,000USD |
| Short Term Investments | 372,465,000USD | 398,726,000USD | 437,894,000USD | 261,667,000USD | 205,380,000USD | 227,778,000USD | 248,475,000USD | 281,347,000USD |
| Total Current Assets | 446,856,000USD | 484,695,000USD | 498,561,000USD | 520,659,000USD | 270,242,000USD | 290,968,000USD | 309,802,000USD | 325,939,000USD |
| Other Current Assets | 10,381,000USD | 7,855,000USD | 8,022,000USD | 7,633,000USD | 9,795,000USD | 5,586,000USD | 4,522,000USD | 5,278,000USD |
| Other Non Current Assets | 1,057,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 36,056,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 28,424,000USD | 17,897,000USD | 19,049,000USD | 14,316,000USD | 11,879,000USD | 9,383,000USD | 8,767,000USD | 7,099,000USD |
| Other Current Liabilities | 23,155,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 422,926,000USD | 471,512,000USD | 484,653,000USD | 511,617,000USD | 263,512,000USD | 285,836,000USD | 305,427,000USD | 323,114,000USD |
| Total Equity Including Noncontrolling Interest | 422,926,000USD | — | — | — | — | — | — | — |
| Net Receivables | 293,000USD | 58,000USD | — | — | — | — | — | — |
| Property Plant Equipment Net | 11,069,000USD | 11,845,000USD | 12,885,000USD | 13,596,000USD | 14,219,000USD | 10,874,000USD | 4,971,000USD | 5,016,000USD |
| Accounts Payable | 2,796,000USD | 6,561,000USD | 4,190,000USD | 3,235,000USD | 3,176,000USD | 2,139,000USD | 1,954,000USD | 1,323,000USD |
| Short Term Debt | 2,473,000USD | 2,615,000USD | 2,755,000USD | 2,482,000USD | 1,759,000USD | 1,008,000USD | 737,000USD | 720,000USD |
| Common Stock | 48,000USD | 48,000USD | 48,000USD | 48,000USD | 37,000USD | 37,000USD | 37,000USD | 36,000USD |
| Retained Earnings | -311,700,000USD | -255,085,000USD | -235,228,000USD | -201,465,000USD | -174,540,000USD | -147,808,000USD | -123,745,000USD | -103,765,000USD |
| Accumulated Other Comprehensive Income | -1,270,000USD | -505,000USD | 546,000USD | 145,000USD | -76,000USD | -95,000USD | -522,000USD | 400,000USD |
| Total Liab | — | 26,085,000USD | 27,778,000USD | 23,706,000USD | 21,983,000USD | 16,217,000USD | 9,506,000USD | 8,030,000USD |
| Other Current Liab | — | 8,721,000USD | 12,104,000USD | 8,599,000USD | 6,944,000USD | 6,236,000USD | 6,076,000USD | 5,056,000USD |
| Capital Stock | — | 48,000USD | 48,000USD | 48,000USD | 37,000USD | 37,000USD | 37,000USD | 36,000USD |
| Cash | — | 78,056,000USD | 52,645,000USD | 251,359,000USD | 55,067,000USD | 57,604,000USD | 56,805,000USD | 39,314,000USD |
| Net Debt | — | -67,253,000USD | -41,161,000USD | -239,487,000USD | -43,204,000USD | -49,762,000USD | -55,329,000USD | -37,663,000USD |
| Short Long Term Debt Total | — | 10,803,000USD | 11,484,000USD | 11,872,000USD | 11,863,000USD | 7,842,000USD | 1,476,000USD | 1,651,000USD |
| Property Plant Equipment Gross | — | 13,775,000USD | 14,867,000USD | 15,314,000USD | 15,682,000USD | 12,084,000USD | 5,936,000USD | 5,721,000USD |
| Common Stock Shares Outstanding | — | 47,236,618shares | 46,978,223shares | 37,931,170shares | 35,444,635shares | 19,288,112shares | 19,288,112shares | 19,170,748shares |
| Non Current Assets Total | — | 12,902,000USD | 13,870,000USD | 14,664,000USD | 15,253,000USD | 11,085,000USD | 5,131,000USD | 5,205,000USD |
| Non Current Liabilities Total | — | 8,188,000USD | 8,729,000USD | 9,390,000USD | 10,104,000USD | 6,834,000USD | 739,000USD | 931,000USD |
| Non Currrent Assets Other | — | 1,057,000USD | 985,000USD | 1,068,000USD | 1,034,000USD | 211,000USD | 160,000USD | 189,000USD |
| Net Working Capital | — | 466,798,000USD | 479,512,000USD | 506,343,000USD | 258,363,000USD | 281,585,000USD | 301,035,000USD | 318,840,000USD |
| Unclassified Non Current Liabilities | — | 8,188,000USD | 8,729,000USD | 9,390,000USD | 10,104,000USD | 6,834,000USD | — | — |
| Unclassified Equity | — | 727,006,000USD | 719,239,000USD | 712,841,000USD | 438,054,000USD | 433,665,000USD | 429,620,000USD | 426,407,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Assets | 512,431,000USD | 314,933,000USD | 155,423,000USD | 31,603,000USD |
| Other Current Assets | 8,022,000USD | 4,522,000USD | 3,394,000USD | 109,000USD |
| Total Liab | 27,778,000USD | 9,506,000USD | 181,057,000USD | 12,098,000USD |
| Total Stockholder Equity | 484,653,000USD | 305,427,000USD | -25,634,000USD | 19,505,000USD |
| Other Current Liab | 12,104,000USD | 6,076,000USD | 5,631,000USD | 213,000USD |
| Common Stock | 48,000USD | 37,000USD | 4,000USD | 31,000USD |
| Capital Stock | 48,000USD | 37,000USD | 4,000USD | 4,000USD |
| Retained Earnings | -235,228,000USD | -123,745,000USD | -45,438,000USD | -10,652,000USD |
| Cash | 52,645,000USD | 56,805,000USD | 70,169,000USD | 31,159,000USD |
| Cash And Short Term Investments | 490,539,000USD | 305,280,000USD | 147,478,000USD | 31,159,000USD |
| Total Current Assets | 498,561,000USD | 309,802,000USD | 150,872,000USD | 31,268,000USD |
| Total Current Liabilities | 19,049,000USD | 8,767,000USD | 8,803,000USD | 1,663,000USD |
| Net Debt | -41,161,000USD | -55,329,000USD | -68,023,000USD | -20,724,000USD |
| Short Term Debt | 2,755,000USD | 737,000USD | 670,000USD | — |
| Short Long Term Debt Total | 11,484,000USD | 1,476,000USD | 2,146,000USD | 10,435,000USD |
| Short Term Investments | 437,894,000USD | 248,475,000USD | 77,309,000USD | 0USD |
| Accounts Payable | 4,190,000USD | 1,954,000USD | 2,502,000USD | 1,450,000USD |
| Property Plant Equipment Net | 12,885,000USD | 4,971,000USD | 4,000,000USD | 335,000USD |
| Property Plant Equipment Gross | 14,867,000USD | 5,936,000USD | 4,127,000USD | 350,000USD |
| Accumulated Other Comprehensive Income | 546,000USD | -522,000USD | 4,000USD | -31,000USD |
| Common Stock Shares Outstanding | 46,978,223shares | 20,738,338shares | 18,078,814shares | 20,117,051shares |
| Non Current Assets Total | 13,870,000USD | 5,131,000USD | 4,551,000USD | 335,000USD |
| Non Current Liabilities Total | 8,729,000USD | 739,000USD | 172,254,000USD | 10,435,000USD |
| Non Currrent Assets Other | 985,000USD | 160,000USD | 551,000USD | — |
| Net Working Capital | 479,512,000USD | 301,035,000USD | 142,069,000USD | 29,605,000USD |
| Unclassified Non Current Liabilities | 8,729,000USD | — | 172,254,000USD | 10,435,000USD |
| Unclassified Equity | 719,239,000USD | 429,620,000USD | 19,792,000USD | 30,153,000USD |
| Other Assets | — | — | 1USD | — |
| Current Deferred Revenue | — | — | -2,502,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -19,857,000USD | -33,763,000USD | -26,925,000USD | -26,732,000USD | -24,063,000USD | -19,980,000USD | -17,537,000USD | -18,121,000USD |
| Depreciation | 227,000USD | 265,000USD | 256,000USD | 252,000USD | 244,000USD | 260,000USD | 219,000USD | 208,000USD |
| Stock Based Compensation | 6,963,000USD | 5,691,000USD | 4,735,000USD | 4,389,000USD | 4,040,000USD | 3,208,000USD | 3,182,000USD | 2,354,000USD |
| Other Non Cash Items | 371,000USD | -501,000USD | 771,000USD | 391,000USD | -25,000USD | 725,000USD | -5,559,000USD | -670,000USD |
| Change To Account Receivables | -58,000USD | — | — | — | 0USD | — | — | — |
| Change In Working Capital | -765,000USD | 3,607,000USD | 3,698,000USD | -3,370,000USD | -433,000USD | 1,341,000USD | 3,280,000USD | -123,000USD |
| Total Cash From Operating Activities | -13,061,000USD | -24,701,000USD | -17,465,000USD | -25,070,000USD | -20,237,000USD | -14,446,000USD | -16,415,000USD | -16,352,000USD |
| Capital Expenditures | -86,000USD | -169,000USD | -134,000USD | -22,000USD | -291,000USD | -226,000USD | -140,000USD | -967,000USD |
| Free Cash Flow | -13,147,000USD | -24,870,000USD | -17,599,000USD | -25,092,000USD | -20,528,000USD | -14,672,000USD | -16,555,000USD | -17,319,000USD |
| Investments | 38,027,000USD | -174,155,000USD | -56,776,000USD | 22,596,000USD | 21,031,000USD | 31,930,000USD | -53,041,000USD | -107,104,000USD |
| Total Cashflows From Investing Activities | 37,941,000USD | -174,324,000USD | -56,776,000USD | 22,596,000USD | 21,031,000USD | 31,930,000USD | -53,041,000USD | -107,104,000USD |
| Total Cash From Financing Activities | 531,000USD | 311,000USD | 270,533,000USD | -63,000USD | 5,000USD | 7,000USD | -1,394,000USD | 159,353,000USD |
| Sale Purchase Of Stock | -5,000USD | 0USD | 0USD | 0USD | -1,000USD | 0USD | 0USD | 0USD |
| Change In Cash | 25,411,000USD | -198,714,000USD | 196,292,000USD | -2,537,000USD | 799,000USD | 17,491,000USD | -70,850,000USD | 35,897,000USD |
| Begin Period Cash Flow | 52,750,000USD | 251,464,000USD | 55,172,000USD | 57,709,000USD | 56,910,000USD | 39,419,000USD | 110,269,000USD | 74,372,000USD |
| End Period Cash Flow | 78,161,000USD | 52,750,000USD | 251,464,000USD | 55,172,000USD | 57,709,000USD | 56,910,000USD | 39,419,000USD | 110,269,000USD |
| Other Cashflows From Investing Activities | 37,941,000USD | -174,324,000USD | -204,000USD | 92,000USD | 436,000USD | — | 3,771,000USD | — |
| Other Cashflows From Financing Activities | -273,000USD | 311,000USD | 63,000USD | — | 6,000USD | 7,000USD | -53,041,000USD | 254,000USD |
| Unclassified Investing Cash Flow | -37,941,000USD | 174,324,000USD | — | — | — | — | -3,631,000USD | — |
| Issuance Of Capital Stock | — | -395,000USD | 269,834,000USD | 0USD | 0USD | 0USD | -1,394,000USD | 159,070,000USD |
| Unclassified Financing Cash Flow | — | — | 270,470,000USD | — | — | — | 51,647,000USD | 159,099,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Net Income | -111,483,000USD | -78,307,000USD | -34,786,000USD | -10,652,000USD |
| Depreciation | 1,017,000USD | 839,000USD | 112,000USD | 16,364USD |
| Stock Based Compensation | 18,855,000USD | 10,235,000USD | 3,525,000USD | 609,818USD |
| Other Non Cash Items | 636,000USD | 4,821,000USD | 1,316,000USD | 5,295,818USD |
| Change In Working Capital | 3,502,000USD | -2,416,000USD | 2,652,000USD | 1,488,000USD |
| Total Cash From Operating Activities | -87,473,000USD | -64,828,000USD | -27,181,000USD | -3,242,000USD |
| Capital Expenditures | -616,000USD | -2,405,000USD | -1,636,000USD | -284,000USD |
| Free Cash Flow | -88,089,000USD | -67,233,000USD | -28,817,000USD | -3,526,000USD |
| Investments | -186,857,000USD | -170,141,000USD | -78,860,000USD | — |
| Total Cashflows From Investing Activities | -187,473,000USD | -170,141,000USD | -78,860,000USD | -5,284,000USD |
| Total Cash From Financing Activities | 270,786,000USD | 221,625,000USD | 145,136,000USD | 39,685,000USD |
| Sale Purchase Of Stock | -1,000USD | 0USD | -4,000USD | — |
| Issuance Of Capital Stock | 269,439,000USD | 221,618,000USD | 145,274,000USD | — |
| Change In Cash | -4,160,000USD | -13,344,000USD | 39,095,000USD | 31,159,000USD |
| Begin Period Cash Flow | 56,910,000USD | 70,254,000USD | 31,159,000USD | — |
| End Period Cash Flow | 52,750,000USD | 56,910,000USD | 70,254,000USD | 31,159,000USD |
| Other Cashflows From Investing Activities | -187,473,000USD | 3,211,000USD | — | -5,000,000USD |
| Other Cashflows From Financing Activities | 270,786,000USD | 63,920,000USD | 145,086,000USD | -5,284,000USD |
| Unclassified Investing Cash Flow | 187,473,000USD | — | 1,636,000USD | — |
| Unclassified Financing Cash Flow | — | 157,705,000USD | — | 44,969,000USD |
| Net Borrowings | — | — | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.